Cell Painting to Accelerate Drug Discovery: Finding Disease Phenotypes and Candidate Therapeutics Using Images Anne Carpenter Senior Director of the Imaging Platform, Institute Scientist, Broad Institute of Harvard and MIT
In response to new business models, accelerated timelines, and unforeseen market dynamics, healthcare companies are seeking to innovate rapidly and effectively to meet new challenges. A key criterion for success is the adoption of cutting-edge tools that derisk and accelerate the drug development process. Investment in these tools pays dividends across a company's pipeline.
Principal Investigator Alex 'Sandy' Pentland
Contact